Staging illustrated with imaging biomarkers along with modifying effects of copathology and cognitive reserve. Credit: Alzheimer’s & Dementia (2024). DOI: 10.1002/alz.13859 The Alzheimer’s Association has published revised criteria for the diagnosis and staging of Alzheimer’s disease that are based on the biology of the disease and reflect recent advancements in research, diagnostics and treatment. “Defining diseases biologically, rather than based on symptoms, has long been standard in many areas of medicine—including cancer, heart disease and diabetes—and is becoming a unifying concept common to all neurodegenerative diseases,” says Clifford Jack Jr., Read More